Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Open Forum Infectious Diseases|August 15, 2019
Acceptability and feasibility of a pharmacist-led HIV pre-exposure prophylaxis (PrEP) program in the Midwestern United StatesJoshua P Havens, Kimberly K Scarsi, Harlan Sayles, et al.
Open Forum Infectious Diseases|February 18, 2025
Utilization of Doxycycline Postexposure Prophylaxis at a Midwestern United States HIV/PrEP ClinicShawnalyn W Sunagawa, Gabriel Codling, Elizabeth Lyden, et al.
Open Forum Infectious Diseases|December 25, 2023
Long-Acting Cabotegravir/Rilpivirine Concentrations in Combination With Intravenous Rifampin: A Case ReportShawnalyn W Sunagawa, Joshua P Havens, Anthony Podany, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|July 1, 1988
Diarrhea in tube-fed burn patients: incidence, etiology, nutritional impact, and preventionM M Gottschlich, G D Warden, M Michel, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|May 1, 1990
Differential effects of three enteral dietary regimens on selected outcome variables in burn patientsM M Gottschlich, M Jenkins, G D Warden, et al.
Open Forum Infectious Diseases|March 13, 2023
Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Patients With HIV-1 Infection and Ongoing Substance Use Disorder: The BASE StudyJoshua P Havens, Sara H Bares, Elizabeth Lyden, et al.
Pediatrics|June 11, 1992
Peripheral intravenous catheter complications in critically ill children: a prospective studyJ S Garland, W M Dunne, P Havens, et al.
Plos One|November 15, 2018
Midwest pharmacists' familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIVJordan M Broekhuis, Kimberly K Scarsi, Harlan R Sayles, et al.
American Journal of Clinical Pathology|March 13, 2021
Clinical Utility of Targeted Next-Generation Sequencing in the Evaluation of Low-Grade Lymphoproliferative DisordersAudrey N Jajosky, Nathaniel P Havens, Navid Sadri, et al.
Open Forum Infectious Diseases|March 16, 2026
Scalability Metrics and Effort Requirements for a Long-Acting Injectable Antiretroviral Treatment ProgramJoshua P Havens, Jennifer O'Neill, Maureen Kubat, et al.
Pageof 4